Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
P09 - Health Services Research/Health Economics - Real World Outcomes
- Type: Posters
- Track: Health Services Research/Health Economics
- Presentations: 60
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P09.01 - Different Administration Routes of Endostar Combined with Chemotherapy in the Treatment of Advanced NSCLC, a Real World Study
00:00 - 00:00 | Presenter: Wei Jiang
- Abstract
Loading... -
+
P09.02 - Impact of COVID-19 in Portuguese Lung Cancer Patients’ Treatment: Portuguese Lung Cancer Study Group Survey
00:00 - 00:00 | Presenter: Fernanda Estevinho
- Abstract
Loading... -
+
P09.03 - Thyroid Dysfunction in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors (ICI): Outcomes in a Multiethnic Urban Cohort.
00:00 - 00:00 | Presenter: Angelica D'Aiello
- Abstract
Loading... -
+
P09.04 - Changing Survival and Treatment Patterns in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC) in Alberta, Canada
00:00 - 00:00 | Presenter: Matthew Anaka
- Abstract
Loading... -
+
P09.05 - Surveillance, Patterns of Recurrence and Survivorship in Early Stage Lung Cancer Patients Following Curative Intent Treatment
00:00 - 00:00 | Author(s): Rob G Stirling
- Abstract
Loading... -
+
P09.06 - CNS Metastasis Negatively Impact Overall Survival of Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Immune Checkpoint Inhibitors.
00:00 - 00:00 | Presenter: Camila Iasmim de Andrade Souza
- Abstract
Loading... -
+
P09.07 - Oncologists Practices and Perceptions on Management of Brain Metastases from Non-Small Cell Lung Cancers-: A Nationally Representative Survey
00:00 - 00:00 | Presenter: Srinivas Chilukuri
- Abstract
Loading... -
+
P09.08 - Age-Related Outcomes of First-Line Pembrolizumab in a Real-World Non-Small-Cell Lung Cancer (NSCLC) Cohort
00:00 - 00:00 | Author(s): Samantha Dolter
- Abstract
Loading... -
+
P09.09 - Overall Survival in Elderly Metastatic Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade
00:00 - 00:00 | Presenter: Maria Fernanda Simões
- Abstract
Loading... -
+
P09.10 - Nationwide Effect of High Procedure Volume in Lung Cancer Surgery on In-House Mortality in Germany
00:00 - 00:00 | Presenter: Philip Baum
- Abstract
Loading... -
+
P09.11 - Nutritional Risk Status Predicts Overall Survival of Mexican Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC).
00:00 - 00:00 | Presenter: Saul Campos-Gomez
- Abstract
Loading... -
+
P09.12 - SARS- CoV2 Impact in a Spanish Lung Cancer Cohort?
00:00 - 00:00 | Author(s): Beatriz Nunez-Garcia
- Abstract
Loading... -
+
P09.13 - Bone Metastases and Overall Survival in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Pembrolizumab
00:00 - 00:00 | Presenter: Parthib Das
- Abstract
Loading... -
+
P09.14 - Predictive Analytics in Real-World Data from Peru: The New Models for Personalized Oncology.
00:00 - 00:00 | Presenter: Luis Pino
- Abstract
Loading... -
+
P09.15 - Severity of Lung Cancer Disease in Hospitalized Patients During COVID-19
00:00 - 00:00 | Presenter: Laia Fernández-Mañas
- Abstract
Loading... -
+
P09.16 - Immunotherapy for Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC). Real-Life Experience from Castile and Leon
00:00 - 00:00 | Presenter: Soledad Medina Valdivieso
- Abstract
Loading... -
+
P09.17 - Changes in the Management of Patients Having Radical Radiotherapy in the UK During the COVID-19 Pandemic (COVID-RT Lung)
00:00 - 00:00 | Presenter: Kathryn Banfill
- Abstract
Loading... -
+
P09.18 - COVID-19 Outcomes in Patients With Thoracic Malignancies According to Gender and Ethnicity (TERAVOLT)
00:00 - 00:00 | Author(s): Jennifer G. Whisenant
- Abstract
Loading... -
+
P09.19 - Health Disparities Characteristics in Cancer Survivorships among Sexual Minorities in the US - A Cross-Sectional Study Using BRFSS 2018 Data
00:00 - 00:00 | Presenter: Yannan Li
- Abstract
Loading... -
+
P09.20 - Impact of Antibiotics During Immune Checkpoint Inhibitor (ICI) Therapy for Non-Small Cell Lung Cancer: A Real-World Analysis
00:00 - 00:00 | Author(s): Andrew Klink
- Abstract
Loading... -
+
P09.22 - Curative Intent Treatment for Small Cell Lung Cancer in England
00:00 - 00:00 | Presenter: Susan Harden
- Abstract
Loading... -
+
P09.23 - Real-World Treatment Patterns and Outcomes in Patients with NSCLC in England (ROSANNE): A Retrospective Study
00:00 - 00:00 | Presenter: Alastair Greystoke
- Abstract
Loading... -
+
P09.24 - Real-World Data in Non-Small Cell Lung Cancer Treated with Checkpoint Inhibitors in a Latin American Institution
00:00 - 00:00 | Presenter: Tania Paytan
- Abstract
Loading... -
+
P09.25 - Role of Immune Checkpoint Inhibitors (ICPi) in KRAS-Mutated Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Monica Peravali
- Abstract
Loading... -
+
P09.26 - Cause of Death in Patients with Squamous Cell Lung Cancer (SCC) Treated with Surgery
00:00 - 00:00 | Presenter: Nirav Nicholas Antao
- Abstract
Loading... -
+
P09.27 - Descriptive Review of Breast Cancer Patients With Subsequent Lung Cancer
00:00 - 00:00 | Presenter: Mah Noor
- Abstract
Loading... -
+
P09.28 - Access to Intermediate and Intensive Care for Patients With Lung Cancer During the COVID-19 Period
00:00 - 00:00 | Presenter: Teresa Gorría
- Abstract
Loading... -
+
P09.29 - Immune-Related Adverse Events and their Association with Effectiveness of PD-1/PD-L1 Inhibitors in NSCLC: A Real-World Study from China
00:00 - 00:00 | Presenter: Xiaoling Chen
- Abstract
Loading... -
+
P09.30 - A Clinical and Molecular Portrait of a Younger Population with Advanced Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Sophie Stock-Martineau
- Abstract
Loading... -
+
P09.31 - Adherence to Treatment Recommendations from Multidisciplinary Tumor Boards
00:00 - 00:00 | Presenter: Julia Roeper
- Abstract
Loading... -
+
P09.32 - Is the New Patient Respiratory Appointment an Appropriate Time to Refer Patients With Likely Lung Cancer for Prehabilitation?
00:00 - 00:00 | Presenter: Lauren Glanville
- Abstract
Loading... -
+
P09.33 - Outcomes of Patients with Lung Cancer Tested for COVID-19 in a Chicago Hospital System (LungCOVID-Chicago)
00:00 - 00:00 | Presenter: Ryan Nguyen
- Abstract
Loading... -
+
P09.34 - Curating Online Journal Clubs to Advance Global Oncology Lung Cancer Care
00:00 - 00:00 | Presenter: Ian J Pereira
- Abstract
Loading... -
+
P09.35 - COVID-19 in Patients with Lung Cancer – Experience from a Thoracic Oncology Center
00:00 - 00:00 | Presenter: David Coelho
- Abstract
Loading... -
+
P09.36 - Impact of Medicaid Enrollment on Mortality in Elderly Dual-Eligible Lung Cancer Patients
00:00 - 00:00 | Presenter: Meera Ragavan
- Abstract
Loading... -
+
P09.37 - Pragmatic Trial Design to Compare Surveillance Strategies for Patients with Small Pulmonary Nodules: The Watch the Spot Trial
00:00 - 00:00 | Presenter: Beth Creekmur
- Abstract
Loading... -
+
P09.38 - 2020: COVID19 Impact in Lung Cancer Resection in a University Hospital of Brazil
00:00 - 00:00 | Presenter: Paulo Alfredo Casanova Schulze
- Abstract
Loading... -
+
P09.39 - PD-L1 Testing Patterns and Treatment in Patients With Metastatic Non-Small Cell Lung Cancer in Israel – Analysis of Real-World Data.
00:00 - 00:00 | Author(s): Lior Apter
- Abstract
Loading... -
+
P09.40 - Treatment Pattern in Patients with Stage III Non-Small-Cell Lung Cancer (NSCLC) in South China
00:00 - 00:00 | Presenter: Joseph Siu-Kie Au
- Abstract
Loading... -
+
P09.41 - Body Mass Index (BMI) Is Associated With Overall Survival in Patients With Metastatic Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Maria Fernanda Medeiros
- Abstract
Loading... -
+
P09.42 - Second-Line Immunotherapy Treatment Patterns in Non-Small Cell Lung Cancer in Portugal: An I-O Optimise Cohort Study
00:00 - 00:00 | Presenter: Marta Soares
- Abstract
Loading... -
+
P09.43 - Familial History of Cancer and Overall Survival in NSCLC Patients.
00:00 - 00:00 | Presenter: Débora Maciel Santana
- Abstract
Loading... -
+
P09.44 - Outcomes of Covid-19 Infection in Lung Cancer Patients: Experience from a Large Tertiary Care Cancer Center
00:00 - 00:00 | Presenter: Kiran Munawar
- Abstract
Loading... -
+
P09.45 - Ten Year Report of Lung Cancer in Never Smokers from Southeast of Brasil
00:00 - 00:00 | Presenter: sabina bandeira Aleixo
- Abstract
Loading... -
+
P09.46 - Non-Small Cell Lung Cancer Comorbid with Tuberculosis is Associated with Better Prognosis
00:00 - 00:00 | Presenter: Ho-Sheng Lee
- Abstract
Loading... -
+
P09.47 - Implementation of Lung Cancer Multidisciplinary Care: A Rapid Review of Evidence-Practice Gaps
00:00 - 00:00 | Presenter: Nicole Rankin
- Abstract
Loading... -
+
P09.48 - Experience and Outcome of COVID-19-Positive Lung Cancer Patients from a Eastern Indian Hospital
00:00 - 00:00 | Author(s): Prasanta Raghab Mohapatra
- Abstract
Loading... -
+
P09.49 - Experience with Immunotherapy Treatment in Fundación Santa Fe Bogotá: Real World Data in Metastatic Non-Small Cell Lung Cancer Patients.
00:00 - 00:00 | Presenter: Aylen Vanessa Ospina Serrano
- Abstract
Loading... -
+
P09.50 - Lung Cancer Hospitalization Burden. Generating Knowledge from Administrative Data to Optimize Management.
00:00 - 00:00 | Author(s): Juan Cristobal Sanchez
- Abstract
Loading... -
+
P09.51 - Lung Adenocarcinoma in Morocco
00:00 - 00:00 | Presenter: Ouassima Erefai
- Abstract
Loading... -
+
P09.52 - Explore-LC: Uniting Existing Real-World Date Sources to Create a Novel Asia-Pacific Wide Research Platform for Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: David Horsburgh
- Abstract
Loading... -
+
P09.53 - Comparative Effectiveness of Crizotinib versus Entrectinib in ROS1+ Non-Small Cell Lung Cancer (NSCLC) using Clinical Trial and Real-World Data
00:00 - 00:00 | Author(s): Michael Groff
- Abstract
Loading... -
+
P09.54 - Pneumonitis Following Durvalumab: A Real-World Analysis in Patients with Lung Cancer and Other Tumor Types
00:00 - 00:00 | Presenter: Ajeet Gajra
- Abstract
Loading... -
+
P09.55 - A Platform to Prospectively Link Real-World Clinico-Genomic, Imaging, and Outcomes Data for Patients With Lung Cancer
00:00 - 00:00 | Presenter: Guneet Walia
- Abstract
Loading... -
+
P09.56 - Real-World Outcomes Among Patients with ROS1-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Author(s): David Waterhouse
- Abstract
Loading... -
+
P09.57 - Estimating the Total US Incidence of Advanced/Metastatic Non-Small Cell Lung (NSCLC) Including Recurrent Disease
00:00 - 00:00 | Author(s): Calvin Huntzinger
- Abstract
Loading... -
+
P09.58 - Replication of Overall Survival in Chemotherapy Arms of 1L NSCLC Trials using Real-World Data External Controls
00:00 - 00:00 | Presenter: Navdeep Pal
- Abstract
Loading... -
+
P09.59 - Real-World Treatment Patterns and Outcomes for Patients With Advanced Non-Small Cell Lung Cancer in Greece
00:00 - 00:00 | Author(s): ELENI Kokkotou
- Abstract
Loading... -
+
P09.60 - Using Patient-Level Data from Electronic Health Records to Replicate PFS Outcomes for Four 1L NSCLC Trials
00:00 - 00:00 | Presenter: Michael T Bretscher
- Abstract
Loading... -
+
P09.61 - Epidemiological and Clinical Burden of EGFR Exon 20 Insertion in Advanced NSCLC: Results of a Systematic Literature Review
00:00 - 00:00 | Author(s): Heather Burnett
- Abstract
Loading...
-
+
P10 - Health Services Research/Health Economics - Health Economics
- Type: Posters
- Track: Health Services Research/Health Economics
- Presentations: 4
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P10.01 - Bias Comparison in Studies Funded by Industry and by Other Sources: An Analysis of Prospective Studies of the Last Five Years
00:00 - 00:00 | Presenter: Silvio Matsas
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
P10.02 - A comparison Between the Cost of Lung Cancer Treatment and how much is made Available by Brazilian Government
00:00 - 00:00 | Presenter: Marina Kelner Silveira
- Abstract
Loading... -
+
P10.03 - Health Insurance Coverage and Racial Disparities in Early-Stage Detection and Treatment of Lung Cancer: A Causal Mediation Analysis
00:00 - 00:00 | Presenter: Zhe Pan
- Abstract
Loading... -
+
P10.04 - A Budget Impact Analysis for Treatment with Ramucirumab Plus Erlotinib in Metastatic EGFR-Mutated NSCLC in the US
00:00 - 00:00 | Author(s): Jonas Nilsson
- Abstract
Loading...
-
+
P11 - Health Services Research/Health Economics - Quality of Life
- Type: Posters
- Track: Health Services Research/Health Economics
- Presentations: 3
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P11.01 - Exploring Patient Reported Quality of Life in Lung Cancer Patients: A Qualitative Study
00:00 - 00:00 | Presenter: Elena Jensen-Marini
- Abstract
Loading... -
+
P11.02 - Patient Reported Outcome Measures (PROM) after Thoracic Surgery: A Pilot Study
00:00 - 00:00 | Presenter: Jitian Zhang
- Abstract
Loading... -
+
P11.03 - Importance of Capturing the Patient Experience of Overall Symptoms and HRQoL Impact in Patients With ALK+ NSCLC
00:00 - 00:00 | Presenter: Yanyan Zhu
- Abstract
Loading...
-
+
P12 - Health Services Research/Health Economics - Health Policy
- Type: Posters
- Track: Health Services Research/Health Economics
- Presentations: 5
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P12.01 - Pilot Training Program, Redesign of the Attention System and Time Reduction on Lung Cancer Patients in a Mexican Hospital
00:00 - 00:00 | Presenter: Saul Campos-Gomez
- Abstract
Loading... -
+
P12.02 - Implementation of a Timeliness-of-care Pathway System for Lung Cancer Patients in a Private Outpatient Oncology Service.
00:00 - 00:00 | Presenter: Iuri Amorim Santana
- Abstract
Loading... -
+
P12.03 - Public Versus Private Care Patients Treated in the Same Hospital. Are the Patients the Same?
00:00 - 00:00 | Author(s): Laura Bittencourt Hinrichsen
- Abstract
Loading... -
+
P12.04 - Access of Lung Cancer to High Technology Radiation Therapy in Brazil
00:00 - 00:00 | Presenter: LILIAN Faroni
- Abstract
Loading... -
+
P12.05 - Current State and Challenges of Lung Cancer Treatment in Georgia
00:00 - 00:00 | Presenter: Elene Mariamidze
- Abstract
Loading...
-
+
P13 - Health Services Research/Health Economics - Misc. Topics
- Type: Posters
- Track: Health Services Research/Health Economics
- Presentations: 5
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P13.01 - Analysis of the Effect of Personalized Nursing in Patients Undergoing Thoracoscopic Surgery for NSCLC
00:00 - 00:00 | Author(s): Li Han
- Abstract
Loading... -
+
P13.02 - Role of Management Checklist in the Prevention and Control of NCP in Oncology Ward
00:00 - 00:00 | Presenter: Li Li
- Abstract
Loading... -
+
P13.03 - The Role of Nurse Practitioners Within Thoracic Radiation Oncology and the Benefit to Patients, Physicians and the Healthcare System
00:00 - 00:00 | Presenter: Ulrike Gorgens
- Abstract
Loading... -
+
P13.04 - Should We Offer Germline Testing to All Patients With Lung Cancer? An Ethical Point of View.
00:00 - 00:00 | Presenter: Guillermo Pacheco-Cuellar
- Abstract
Loading... -
+
P13.05 - Real-World Treatment Patterns and Sequencing of Immunotherapy and Chemotherapy Based on PD-L1 TPS in European Patients With mNSCLC
00:00 - 00:00 | Author(s): Megan Nicole Gower
- Abstract
Loading...
-
+
P14 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Immuno-Biology
- Type: Posters
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
- Presentations: 30
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P14.01 - Impact of Stimulator of Interferon Genes (STING) Signaling on the Tumor Immune Microenvironment in Lung Adenocarcinoma
00:00 - 00:00 | Author(s): Lingling Zhu
- Abstract
Loading... -
+
P14.02 - Expression and Significance of Indoleamine 2,3 Dioxygenase on Tumor Cell and Tumor Stroma Compartments of Lung Squamous Cell Carcinoma
00:00 - 00:00 | Presenter: Wei Wang
- Abstract
Loading... -
+
P14.03 - Histotype-dependent Associations of LAG-3 Expression with Clinicopathologic Features and Survival in Non-small Cell Lung Cancer
00:00 - 00:00 | Presenter: Dan Shepherd
- Abstract
Loading... -
+
P14.04 - cfRNA from Liquid Biopsies Is More Abundant Than cfDNA, Informs Treatment Outcome and Is Concordant with Tissue
00:00 - 00:00 | Presenter: Luis E. Raez
- Abstract
Loading... -
+
P14.05 - The Relationship Between Genomic Alterations and the Efficacy of Immune Check Point Inhibitor for KRAS Mutated Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Naoki Furuya
- Abstract
Loading... -
+
P14.06 - Dysregulation of m6a Reader IGF2BP1 in Lung Adenocarcinoma Affects the Immune Microenvironment and Indicates a Poor Recovery
00:00 - 00:00 | Presenter: Xuequan Wang
- Abstract
Loading... -
+
P14.07 - Clinically Predictive Value of Plasma Cell-Free DNA in Lung Cancer Immunotherapy
00:00 - 00:00 | Author(s): Jiangyong Yu
- Abstract
Loading... -
+
P14.09 - Early Expansion of M-MDSCs and High Plasma TSLP levels as Predictors of Primary Resistance to PD1 Inhibitors in Metastatic NSCLC
00:00 - 00:00 | Presenter: Sally Chui Mei Lau
- Abstract
Loading... -
+
P14.10 - Efficacy of Anti-PD-1/PD-L1 Monoclonal Antibody Treatment of Advanced NSCLC on Density and Distribution of Tumor Infiltrating T Cells
00:00 - 00:00 | Presenter: Yuanyong Wang
- Abstract
Loading... -
+
P14.11 - Optimal Combination of Biomarkers to Improve the Predictive Value of Immunotherapeutic Response in Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Soohyeon Kwon
- Abstract
Loading... -
+
P14.12 - MET Amplification and Immune Checkpoint Inhibitor Efficacy in NSCLC
00:00 - 00:00 | Presenter: shan Su
- Abstract
Loading... -
+
P14.13 - Notch Family Gene Mutations Predict Clinical Benefit from Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Huaqiang Zhou
- Abstract
Loading... -
+
P14.14 - PTPRD: A Positive Predictive Biomarker for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Jiayi Shen
- Abstract
Loading... -
+
P14.15 - Circulating Tumor DNA Predict the Response and Survival after Tislelizumab Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
00:00 - 00:00 | Presenter: qiong He
- Abstract
Loading... -
+
P14.16 - The Early Landscape of Immune Cell Subsets in Metastatic NSCLC Patients Treated with Immune Checkpoint Inhibitors
00:00 - 00:00 | Presenter: Jianguo Zhou
- Abstract
Loading... -
+
P14.17 - Low BMI is Associated with Inferior Overall Survival in HIV Patients with Advanced NSCLC Undergoing Immunotherapy
00:00 - 00:00 | Presenter: Emily Lin
- Abstract
Loading... -
+
P14.18 - Expression and Clinical Significance of CMTM6 in Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Sisi He
- Abstract
Loading... -
+
P14.19 - CD8α-Enhanced NY-ESO-1-Specific TCR T Cells (GSK3901961) in HLA-A*02 Patients with NSCLC: Master Protocol Substudy 1
00:00 - 00:00 | Presenter: Mehmet Altan
- Abstract
Loading... -
+
P14.20 - Multi-Spectral Imaging of Lung Adenocarcinoma Reveals Importance of Cancer Specific HLA-DR on the TME and Clinical Outcome
00:00 - 00:00 | Author(s): Amber Johnson
- Abstract
Loading... -
+
P14.21 - Baseline Derived Neutrophil-to-Lymphocyte Ratio (dNLR) and Clinical Outcomes to First-Line Pembrolizumab in NSCLC with High PD-L1 (≥50%)
00:00 - 00:00 | Presenter: Joao Victor M. Alessi
- Abstract
Loading... -
+
P14.22 - Radiotherapy With Sequential αnti-PD-1 mAb Is Better in Enhancing the Abscopal Effect by Promoting the Inflammatory Tumor Microenvironment
00:00 - 00:00 | Presenter: Xiaoxia Zhu
- Abstract
Loading... -
+
P14.23 - Different in Situ Immune Pattern Between Primary Tumor and Metastatic Lymph Node in NSCLC: Potential Impact on Neoadjuvant Immunotherapy
00:00 - 00:00 | Presenter: Ze-Rui Zhao
- Abstract
Loading... -
+
P14.24 - Evolution of TCR Clonality during Chemoradiation and Durvalumab as Predictors of Survival in Stage 3 NSCLC
00:00 - 00:00 | Presenter: Sally Chui Mei Lau
- Abstract
Loading... -
+
P14.25 - Immune Cell Profiling of Hyperprogressive Disease in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Antibodies
00:00 - 00:00 | Presenter: Kyung Hwan Kim
- Abstract
Loading... -
+
P14.26 - Diminished Efficacy of PD-(L)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma is Impacted by KRAS Mutation Status
00:00 - 00:00 | Presenter: Biagio Ricciuti
- Abstract
Loading... -
+
P14.27 - Pathogenic Genomic Alterations of CDKN2A Predict Immunotherapy Resistance in NSCLC
00:00 - 00:00 | Presenter: Stanley Gutiontov
- Abstract
Loading... -
+
P14.28 - Association Between the Type of First-Line Chemotherapy and Outcome of Second-Line Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Mihyun Kim
- Abstract
Loading... -
+
P14.29 - Toripalimab in Combination with CIK Cells in Patients with Advanced NSCLC: An Exploratory Study
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading... -
+
P14.32 - Predictive Value of Neutrophil-Lymphocyte Ratio on the Outcome of Patients with Advance NSCLC Treated with PD-1 Inhibition and Radiotherapy
00:00 - 00:00 | Author(s): Kevin A D'Rummo
- Abstract
Loading... -
+
P14.33 - Soluble PD-L1 as Biomarker of Benefit from Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Carlo Genova
- Abstract
Loading...
-
+
P15 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Novel Immunotherapeutics (Phase I)
- Type: Posters
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
- Presentations: 8
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P15.01 - AMG 757, a Half-Life Extended Bispecific T-Cell Engager (HLE BiTE® Immune Therapy) Targeting DLL3, for the Treatment of Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Keegan Cooke
- Abstract
Loading... -
+
P15.02 - Phase Ib Study to Evaluate the Safety and Efficacy of Osimertinib in Combination with Ipilimumab in EGFR Mutated NSCLC
00:00 - 00:00 | Presenter: Sonam Puri
- Abstract
Loading... -
+
P15.03 - A Phase 1/1b Study of Lazertinib as Monotherapy and in Combination with Amivantamab in Advanced EGFR-Mutated NSCLC
00:00 - 00:00 | Presenter: Koichi Goto
- Abstract
Loading... -
+
P15.04 - A Phase I/IB Trial of Pembrolizumab and Trametinib Focused on Advanced KRAS Mutant Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Jonathan Riess
- Abstract
Loading... -
+
P15.06 - Safety of BMS-986012, an Anti–Fucosyl-GM1 Monoclonal Antibody Plus Platinum/Etoposide in Untreated Extensive-Stage SCLC
00:00 - 00:00 | Presenter: Luis G. Paz-Ares
- Abstract
Loading... -
+
P15.07 - Safety and Efficacy Profile of TQB-2450 Alone/with Anlotinib in Previously-Treated Advanced NSCLC: A Phase IB Single-Arm Trial
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading... -
+
P15.08 - Phase I Trial of in situ Vaccination With Autologous CCL21-Modified Dendritic Cells (CCL21-DC) Combined With Pembrolizumab for Advanced NSCLC
00:00 - 00:00 | Presenter: Aaron Lisberg
- Abstract
Loading... -
+
P15.09 - A Promising Result of Two Therapeutic Peptides Combined with Chemotherapy in the Treatment of Advanced NSCLC.
00:00 - 00:00 | Presenter: Jiangnan Feng
- Abstract
Loading...
-
+
P16 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Novel Immunotherapeutics (Translational)
- Type: Posters
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
- Presentations: 7
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P16.01 - The Effect of Different Dose and Sites of Irradiation on Lymphocyte Subsets in Peripheral Blood of Patients With Lung Cancer
00:00 - 00:00 | Presenter: Xiaoxia Zhu
- Abstract
Loading... -
+
P16.02 - Impact of Number and Location of Metastatic Sites on Survival in Stage IV ICI-Treated NSCLC
00:00 - 00:00 | Presenter: Amanda Jane Williams Gibson
- Abstract
Loading... -
+
P16.03 - Early Mortality Associated Factors With Immune Checkpoint Inhibition in Real-World Canadian NSCLC Patients
00:00 - 00:00 | Presenter: Amanda Jane Williams Gibson
- Abstract
Loading... -
+
P16.04 - CDK4/6 Inhibitors Reverse Resistance to Anti-PD-1 Therapy in Lung Adenocarcinoma with LKB1 Deficiency Through pRB-ICAM1 Dependent Signaling
00:00 - 00:00 | Presenter: Zhong-Yi Dong
- Abstract
Loading... -
+
P16.05 - Exploratory Study of Sintilimab Intrapleural Therapy for NSCLC-Mediated Malignant Pleural Effusion
00:00 - 00:00 | Presenter: Tangfeng Lv
- Abstract
Loading... -
+
P16.06 - Exploration of Efficacy and irAEs of Pembrolizumab Plus Chemotherapy for Advanced NSCLC as 1st Line Treatment in Real World
00:00 - 00:00 | Presenter: Teng Li
- Abstract
Loading... -
+
P16.07 - Immuno-Modulatory Effects of Ceralasertib in Combination with Durvalumab in NSCLC with Progression on Anti-PD(L)1 Treatment (HUDSON)
00:00 - 00:00 | Author(s): Marylens Hernandez
- Abstract
Loading...
-
+
P17 - Locoregional and Oligometastatic Disease - Biomarkers
- Type: Posters
- Track: Locoregional and Oligometastatic Disease
- Presentations: 3
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P17.01 - Adaptive Elastic-Net Nomogram Predicting Disease-Free Survival in Resected Stage IIIA (N2) Non–Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Chenchen Zhang
- Abstract
Loading... -
+
P17.02 - Durvalumab After chemoRadioTherapy (DART) for NSCLC Patients – a Phase II Translational and Biomarker Study
00:00 - 00:00 | Presenter: Vilde Drageset Haakensen
- Abstract
Loading... -
+
P17.03 - Lung Adenocarcinoma with Lymph Node Metastasis: Is Ground Glass Opacity Component a Prognostic Factor?
00:00 - 00:00 | Presenter: Xiangyi Ma
- Abstract
Loading...
-
+
P18 - Locoregional and Oligometastatic Disease - Misc. Topics
- Type: Posters
- Track: Locoregional and Oligometastatic Disease
- Presentations: 6
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P18.01 - Prognostic Value of the LIPI in Patients with LA-NSCLC Receiving Definitive RT: A Retrospective Study of 1079 Patients
00:00 - 00:00 | Presenter: Wenji Xue
- Abstract
Loading... -
+
P18.02 - Factors Influencing Multi-Disciplinary Tumor Board Recommendations in Stage III Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Merle Ilona Ronden
- Abstract
Loading... -
+
P18.03 - Randomized Trial With BIALOE to Prevent Esophagitis in Lung Cancer Patients Treated With Concurrent Radical Chemoradiotherapy
00:00 - 00:00 | Presenter: Francesc Casas
- Abstract
Loading... -
+
P18.04 - Individualized Fraction Regimen of SBRT Patients with Non-small Cell Lung Cancer Based on Uncomplicated and Cancer-free Control Probability
00:00 - 00:00 | Presenter: AiHui Feng
- Abstract
Loading... -
+
P18.05 - Immunotherapy Beyond First-Line in NSCLC, Still An Option.
00:00 - 00:00 | Presenter: Andrea Modrego
- Abstract
Loading... -
+
P18.06 - Retrospective Epidemiological Study of Locally Advanced Non-Small Cell Lung Cancer Patients in Brazil – RELANCE (LACOG 0118)
00:00 - 00:00 | Presenter: Vladmir Claudio Cordeiro De Lima
- Abstract
Loading...
first
prev
